Article Text

PDF
SAT0643-HPR Points To Consider for Health Professionals Undertaking Musculoskeletal Ultrasound for Rheumatic and Musculoskeletal Diseases: Progress of A Eular Task Force
  1. H.J. Siddle1,
  2. P. Mandl2,
  3. D. Aletaha2,
  4. T.P. Vliet Vlieland3,
  5. M. Backhaus4,
  6. P. Cornell5,
  7. M.A. D'Agostino1,6,
  8. K. Ellegaard7,
  9. A. Iagnocco8,
  10. B. Jakobson9,
  11. T. Jasinski10,
  12. N.H. Kildal11,
  13. M. Lehner2,
  14. I. Möller12,
  15. G.M. Supp2,
  16. P. O'Connor13,
  17. A.C. Redmond1,
  18. E. Naredo14,
  19. R.J. Wakefield1
  1. 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom
  2. 2Division of Rheumatology, Medical University of Vienna, Vienna, Austria
  3. 3Department of Orthopaedics, Rehabilitation amd Physical Therapy, Leiden University Medical Centre, Leiden, Netherlands
  4. 4Department of Internal Medicine, Rheumatology and Clinical Immunology, Academic Hospital of the Charité Berlin, Berlin, Germany
  5. 5Rheumatology, Poole Hospital NHS Foundation Trust, Poole, United Kingdom
  6. 6Laboratoire d'Excellence INFLAMEX, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines, France
  7. 7The Parker Institute, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark
  8. 8Rheumatology Unit - Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Rome, Italy
  9. 9Norwegian National Advisory Unit on Pregnancy and Rheumatic Diseases, St. Olavs Hospital, Trondheim, Norway
  10. 10Patient Research Partner, Estonian Rheumatism Association, Tallinn, Estonia
  11. 11Faculty of Health and Social Science, Norwegian University of Science and Technology, Trondheim, Norway
  12. 12Instituto Poal de Reumatologia, Barcelona, Spain
  13. 13Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
  14. 14Department of Rheumatology, Hospital GU Gregorio Marañόn, Madrid, Spain

Abstract

Background Musculoskeletal ultrasound (MSUS) has evolved into an important method for identifying musculoskeletal abnormalities, confirming the diagnosis in patients with suspected inflammatory arthritis, monitoring therapeutic response, influencing clinical decision making and guiding interventions. The role of the non-medical health professional has advanced with many health professionals undertaking training and using MSUS to extend their scope of practice. Guidelines to support training for rheumatologists have been identified but currently there are not any recommendations to support the education and training needs of non-medical health professionals using MSUS.

Objectives The EULAR Task Force was established to reach a consensus on the role and education and training needs of non-medical health professionals undertaking MSUS for the management of patients with rheumatic and musculoskeletal diseases (RMDs).

Methods The EULAR Task Force comprised an expert group from 11 European countries. The Task Force met twice and included rheumatologists, nurses, physiotherapists, a radiologist, radiographer and podiatrist with patient representation. In the first meeting the aims of the Task Force were defined and fourteen research questions were developed. This was followed by a comprehensive systematic search of the literature to identify publications on the role of health professionals using MSUS, their competency requirements and training undertaken. During the second meeting the Task Force were presented with the results of the literature review which supported the formulation and consensus of “points to consider”. The level of agreement between task force members for each “point to consider” was determined after the second meeting.

Results In total, seven “points to consider” were formulated. Two points covered the role and scope of health professionals using musculoskeletal ultrasound and one point addressed the application and feasibility in daily practice. Three “points to consider” focused on the training and competency required by health professionals and the final point addressed the added value in daily practice. The strength of the “points to consider” was D based on the category of evidence (3–4). A high level of agreement (range 9.0–9.7) was achieved between Task Force members. Additionally, the Task Force agreed upon eight topics for the future research agenda.

Conclusions Seven “points to consider” for health professionals using MSUS for the management of patients with RMDs were developed using a combination of research-based evidence and expert consensus approach.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.